|
| (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol Basic information | Appearance |
Product Name: | (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol | Synonyms: | (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol;a-D-Glucopyranoside, Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-;Methyl 1-C-[4-chloro-3-(4-ethoxybenzyl)phenyl]-α-D-Glucopyranoside;DAPAGLIFLOZIN intermediate;Dapagliflozin Intermediate 3;Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-alpha-D-glucopyranoside;(2S,3R,4S,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)-2-methoxy-tetrahydropyran-3,4,5-triol;(2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol###461432-23-5 | CAS: | 714269-57-5 | MF: | C22H27ClO7 | MW: | 438.9 | EINECS: | 615-293-6 | Product Categories: | | Mol File: | 714269-57-5.mol | |
| (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol Chemical Properties |
Melting point | >80°C (dec.) | Boiling point | 609.6±55.0 °C(Predicted) | density | 1.39±0.1 g/cm3 (20 ºC 760 Torr) | storage temp. | 2-8°C | solubility | Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly), Water (Slightly) | form | Solid | pka | 12.59±0.70(Predicted) | color | White to Off-White | Stability: | Hygroscopic |
| (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol Usage And Synthesis |
Appearance | Solid | Uses | 1α-Methyl Dapagliflozin is an antidiabetic agent and intermediate of Dapagliflozin (D226255]), a sodium-glucose transporter 2 inhibitor. |
| (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol Preparation Products And Raw materials |
|